Et tu, J&J?


I always think of Johnson & Johnson as one of the good guys, so it was very disheartening to read this article in the New York Times (free reg. req'd): Lucrative Drug, Danger Signals and the F.D.A. about its heartburn drug, Propulsid. A snip:

Propulsid's history has striking parallels with the painkillers now at the

center of controversy. Dozens of studies sponsored by Johnson & Johnson that

might have warned doctors away were never published, just as the pharmaceutical

manufacturer Pfizer

failed to publish an early study of Celebrex that indicated a heart risk. And

Johnson & Johnson was able to delay and soften some proposed label changes,

just as Merck

later did with Vioxx.

Please or Register to post comments.

Blog Archive

Sponsored Introduction Continue on to (or wait seconds) ×